MétaCan
Menu
Back to cohort
Record W4414049520 · doi:10.1055/s-0045-1810775

Seladelpar treatment of patients with primary biliary cholangitis improves the GLOBE score and predicts improved transplant-free survival

2025· article· en· W4414049520 on OpenAlexaff
Bettina E. Hansen, A Teufel, Sandra Carroll, Yanlai Zhou, Carla Perez, Gideon M. Hirschfield

Bibliographic record

VenueZeitschrift für Gastroenterologie · 2025
Typearticle
Languageen
FieldMedicine
TopicLiver Diseases and Immunity
Canadian institutionsToronto Liver CentreInstitute of Health Services and Policy Research
Fundersnot available
KeywordsIncidence (geometry)Survival analysisClinical trialRetrospective cohort studyMEDLINE

Abstract

fetched live from OpenAlex

Introduction: The GLOBE score is a validated risk assessment tool used to estimate transplant-free survival (TFS) in patients (pts) with primary biliary cholangitis (PBC). Seladelpar (SEL) is a first-in-class delpar (selective PPAR-delta agonist) indicated for the treatment of PBC in combination with ursodeoxycholic acid (UDCA) in pts who have an inadequate response to UDCA, or as a monotherapy in pts unable to tolerate UDCA. Objectives: This study evaluated the change in GLOBE score in pts with PBC on SEL from the placebo (PBO)-controlled Phase 3 RESPONSE (NCT04620733) trial and the subsequent open-label extension (ASSURE; NCT03301506). Methodology: Pts with PBC who received UDCA for≥12 months (M) or were intolerant to UDCA and had alkaline phosphatase (ALP)≥1.67×the upper limit of normal (ULN) and total bilirubin (TB)≤2×ULN were enrolled in RESPONSE and randomised 2:1 to receive daily SEL 10 mg or PBO. After 1 year (Y), pts were eligible for ASSURE, in which pts on PBO could switch to SEL (crossover) and pts on SEL continued treatment (continuous). Change in GLOBE score, predicted TFS, and the contributions of ALP, TB, albumin, and platelets to changes in GLOBE score were evaluated. Results: 193 pts were enrolled; 95% were female. At baseline (BL), mean (SD) age and duration of PBC were 57 (9.7) and 8 (6.6) years, with mean (SD) ALP: 314 (120.9) U/L; TB: 0.76 (0.31) mg/dL; albumin: 4.1 (0.26) g/dL; platelets: 242 (80.6)×10 3 /uL; and GLOBE score: 0.32 (0.68). Mean (SD) changes in GLOBE score from BL at 3M and 1Y for pts on SEL were−0.38 (0.21) and−0.34 (0.39), respectively, vs−0.07 (0.28) and−0.01 (0.32) for pts on PBO. At 2Y, GLOBE score changes were−0.39 (0.33) and−0.42 (0.50) for pts on continuous or crossover SEL, respectively. For pts on SEL, the greatest changes in GLOBE score were attributable to the ALP component (3M,−0.20; 1Y,−0.21; 2Y,−0.19), followed by the TB component (3M,−0.11; 1Y,−0.09; 2Y,−0.13). SEL treatment for 3M, 1Y, and 2Y led to predicted changes in TFS with hazard ratios (HRs [95% CIs]) of 0.7 (0.7–0.7), 0.8 (0.7–0.9), and 0.7 (0.6–0.8) compared with BL, respectively; HRs (95% CIs) for pts on PBO at 3M and 1Y were 1.0 (0.9–1.0) and 1.0 (1.0–1.1). At 2Y, pts on crossover SEL had similar results to those on continuous SEL. Conclusion: SEL treatment resulted in an early decrease in GLOBE score for pts with PBC, which was maintained over 2Y and was associated with improved predicted TFS. Publication History Article published online: 04 September 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.011
GPT teacher head0.234
Teacher spread0.223 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractno

Explore more

Same venueZeitschrift für GastroenterologieSame topicLiver Diseases and ImmunityFrench-language works237,207